A small molecule enhances RNA interference and promotes microRNA processing

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Nature Biotechnology

• Publication date

  2008-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/nbt.1481PMID 18641635PMCID PMC2831467
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Specific residues at every third position of siRNA shape its efficient RNAi activity

  2007cited by this paper
• Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA.

  2007cited by this paper
• Micro RNAs in animal development.

  2006cited by this paper
• Demystifying small RNA pathways.

  2006cited by this paper
• Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity.

  2006cited by this paper
• Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs.

  2006cited by this paper
• [The big world of the small RNAs].

  2006cited by this paper
• Translation Repression in Human Cells by MicroRNA-Induced Gene Silencing Requires RCK/p54

  2006cited by this paper
• Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents.

  2005cited by this paper
• Ribo-gnome: The Big World of Small RNAs

  2005cited by this paper
• Normal microRNA Maturation and Germ-Line Stem Cell Maintenance Requires Loquacious, a Double-Stranded RNA-Binding Domain Protein

  2005cited by this paper
• TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing

  2005cited by this paper
• Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

  2005cited by this paper
• The silent revolution: RNA interference as basic biology, research tool, and therapeutic.

  2005cited by this paper
• Involvement of microRNA in AU-rich element-mediated mRNA instability.

  2005cited by this paper
• Dicer-1 and R3D1-L catalyze microRNA maturation in Drosophila.

  2005cited by this paper
• Sequence-Specific Inhibition of Small RNA Function

  2004cited by this paper
• Biochemical identification of Argonaute 2 as the sole protein required for RNA-induced silencing complex activity.

  2004cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• Argonaute2 Is the Catalytic Engine of Mammalian RNAi

  2004cited by this paper
• Correction

  2004cited by this paper
• The expanding role of fluoroquinolones.

  2003cited by this paper
• Immunomodulatory effects of quinolones.

  2003cited by this paper
• A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA

  2003cited by this paper
• Several gene programs are induced in ciprofloxacin‐treated human lymphocytes as revealed by microarray analysis

  2003cited by this paper
• RNA interference

  2002cited by this paper
• The expanding role of fluoroquinolones.

  2002cited by this paper
• Role for a bidentate ribonuclease in the initiation step of RNA interference

  2001cited by this paper
• The chemical and biological aspects of fluoroquinolones: reality and dreams.

  2001cited by this paper
• RNA Interference

  2000cited by this paper
• ‘Green mice’ as a source of ubiquitous green cells

  1997cited by this paper
• Reality and Dreams

  1996cited by this paper
• Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections.

  1996cited by this paper
• Quinolone antimicrobial agents

  1993cited by this paper
• Quinolone antimicrobial agents.

  1992cited by this paper
• Insight Review Articles

  year unknowncited by this paper
• References and Notes Materials and Methods Som Text Fig. S1 Table S1 References a Microrna in a Multiple- Turnover Rnai Enzyme Complex

  year unknowncited by this paper

• Canonical microRNA loss drives tumor development implicating therapeutic efficacy of enoxacin in angiosarcoma.

  2026cites this paper
• Theme 9 Clinical Trials and Trial Design

  2025cites this paper
• The most recent updates on the anticancer potential of fluoroquinolones: a mini review.

  2025cites this paper
• Emerging frontiers in microRNA technology: Innovations driving precision medicine.

  2025cites this paper
• Structural optimization and pharmacological evaluation of diphenyl amine esters as anti-hepatocellular carcinoma agents by targeting TAR RNA-binding protein 2.

  2025cites this paper
• Advances in miRNA research: Unraveling the complexities of gene regulation

  2025cites this paper
• The cleavage of dsRNA by StaufenC into siRNA affects the RNAi efficiency in the 28-spotted ladybeetle, Henosepilachna vigintioctopunctata.

  2025cites this paper
• Design of a nano-pesticide combining luvangetin and RNAi for high-efficiency green management of plant pathogens

  2025cites this paper
• RNA Interference Targeting Small Heat Shock Protein B8 Failed to Improve Distal Hereditary Motor Neuropathy in the Mouse Model

  2025cites this paper
• Canonical microRNA loss drives tumor development implicating therapeutic efficacy of enoxacin in angiosarcoma

  2025cites this paper
• MicroRNAs in neurodegenerative diseases: from molecular mechanisms to clinical biomarkers, detection methods and therapeutic strategies—advances and challenges

  2025cites this paper
• Elucidating the Synergistic Effect of the PrimeC Combination for Amyotrophic Lateral Sclerosis in Human Induced Pluripotent Stem Cell-Derived Motor Neurons and Mouse Models

  2025cites this paper
• In Silico Evaluation of Some Computer-Designed Fluoroquinolone–Glutamic Acid Hybrids as Potential Topoisomerase II Inhibitors with Anti-Cancer Effect

  2024cites this paper
• Anti-HIV-1 Effect of the Fluoroquinolone Enoxacin and Modulation of Pro-Viral hsa-miR-132 Processing in CEM-SS Cells

  2024influential citation
• Elemene as a binding stabilizer of microRNA-145-5p suppresses the growth of non-small cell lung cancer

  2024cites this paper
• Drug regulation of microRNA

  2024cites this paper
• Evaluating emerging drugs in phase II & III for the treatment of amyotrophic lateral sclerosis

  2024cites this paper
• DNA damage response defects induced by the formation of TDP-43 and mutant FUS cytoplasmic inclusions and their pharmacological rescue

  2024cites this paper
• New insights into the function and therapeutic potential of RNA-binding protein TRBP in viral infection, chronic metabolic diseases, brain disorders and cancer.

  2024cites this paper
• HTFSMMA: Higher-Order Topological Guided Small Molecule–MicroRNA Associations Prediction

  2024cites this paper
• New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery

  2024cites this paper
• Heterogeneous graph inference with range constrainted L2,1-collaborative matrix factorization for small molecule-miRNA association prediction

  2024cites this paper
• RNA interference, an emerging component of antiviral immunity in mammals.

  2023cites this paper
• Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma

  2023cites this paper
• A microRNA Arising from the Negative Strand of SARS-CoV-2 Genome Targets FOS to Reduce AP-1 Activity

  2023cites this paper
• Zika virus co-opts miRNA networks to persist in placental niches detected by spatial transcriptomics.

  2023cites this paper
• AMCSMMA: Predicting Small Molecule–miRNA Potential Associations Based on Accurate Matrix Completion

  2023cites this paper
• 4-Hydroxynonenal impairs miRNA maturation in heart failure via Dicer post-translational modification.

  2023cites this paper
• Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis

  2023cites this paper
• Alphavirus infection triggers antiviral RNAi immunity in mammals.

  2023cites this paper
• Death Induced by Survival gene Elimination (DISE) correlates with neurotoxicity in Alzheimer’s disease and aging

  2023cites this paper
• Multiplex miRNA reporting platform for real-time profiling of living cells.

  2023cites this paper
• The role of genes of the Argonaute family in the effects of the RNA interference activator enoxacin on the lifespan of Drosophila melanogaster

  2023cites this paper
• MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies

  2022cites this paper
• Design, synthesis, and evaluation of fluoroquinolone derivatives as microRNA-21 small-molecule inhibitors

  2022cites this paper
• Missing Causality and Heritability of Autoimmune Hepatitis

  2022cites this paper
• Targeting non-coding RNA family members with artificial endonuclease XNAzymes

  2022cites this paper
• Death induced by survival gene elimination (DISE) contributes to neurotoxicity in Alzheimer's disease

  2022cites this paper
• The New Face of a Well-Known Antibiotic: A Review of the Anticancer Activity of Enoxacin and Its Derivatives

  2022influential citation
• The NS4A Protein of Classical Swine Fever Virus Suppresses RNA Silencing in Mammalian Cells

  2022cites this paper
• Non-coding RNA in rhabdomyosarcoma progression and metastasis

  2022cites this paper
• Targeting TGF-β1/miR-21 Pathway in Keratinocytes Reveals Protective Effects of Silymarin on Imiquimod-Induced Psoriasis Mouse Model

  2022cites this paper
• Možnosti uporabe protimikrobnih učinkovin pri

  2022cites this paper
• Examining micro-ribonucleic acids as diagnostic and therapeutic prospects in autoimmune hepatitis

  2022cites this paper
• Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS

  2022cites this paper
• DExD/H-box helicases in HIV-1 replication and their inhibition.

  2022cites this paper
• TDP-43 and NEAT long non-coding RNA: Roles in neurodegenerative disease

  2022cites this paper
• Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy

  2022cites this paper
• MicroRNAs modulate neuroinflammation after intracerebral hemorrhage: Prospects for new therapy

  2022cites this paper
• Cholangiopathies and the noncoding revolution

  2022cites this paper
• Non-Coding RNAs: New Dawn for Diabetes Mellitus Induced Erectile Dysfunction

  2022cites this paper
• Possible use of antimicrobial agents in cancer therapy

  2022cites this paper
• Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy

  2021cites this paper
• DISE/6mer seed toxicity-a powerful anti-cancer mechanism with implications for other diseases

  2021cites this paper
• HT-SELEX-based identification of binding pre-miRNA hairpin-motif for small molecules

  2021cites this paper
• Dual-Network Collaborative Matrix Factorization for predicting small molecule-miRNA associations

  2021cites this paper
• The Role of RNA in DNA Breaks, Repair and Chromosomal Rearrangements

  2021cites this paper
• The Challenges and Opportunities in the Development of MicroRNA Therapeutics: A Multidisciplinary Viewpoint

  2021cites this paper
• MicroRNAs Regulating Autophagy in Neurodegeneration.

  2021cites this paper
• Synthetic RNA Modulators in Drug Discovery.

  2021cites this paper
• Enoxacin Shows Broad-Spectrum Antiviral Activity against Diverse Viruses by Enhancing Antiviral RNA Interference in Insects

  2021influential citation
• Enoxacin Up‐Regulates MicroRNA Biogenesis and Down‐Regulates Cytotoxic CD8 T‐Cell Function in Autoimmune Cholangitis

  2021cites this paper
• Identification of a Novel TAR RNA-Binding Protein 2 Modulator with Potential Therapeutic Activity against Hepatocellular Carcinoma.

  2021cites this paper
• Advances in the role of natural products in human gene expression.

  2021cites this paper
• Modulating intracellular pathways to improve non-viral delivery of RNA therapeutics.

  2021cites this paper
• Deficiency of DICER reduces the invasion ability of trophoblasts and impairs the pro‐angiogenic effect of trophoblast‐derived microvesicles

  2020cites this paper
• Old Drugs with New Tricks: Efficacy of Fluoroquinolones to Suppress Replication of Flaviviruses

  2020influential citation
• Evolution of resistance to fluoroquinolones by dengue virus serotype 4 provides insight into mechanism of action and consequences for viral fitness

  2020cites this paper
• In silico analysis suggests the RNAi-enhancing antibiotic enoxacin as a potential inhibitor of SARS-CoV-2 infection

  2020cites this paper
• Epigenetic regulation mediated by antisense non-coding RNAs and its impact on oncogenic pathways: the HMGA2/RPSAP52 locus

  2020cites this paper
• Pathogenetic Role and Clinical Implications of Regulatory RNAs in Biliary Tract Cancer

  2020cites this paper
• Small interfering RNA for cancer treatment: overcoming hurdles in delivery

  2020cites this paper
• Enoxacin induces oxidative metabolism and mitigates obesity by regulating adipose tissue miRNA expression

  2020influential citation
• Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury

  2020cites this paper
• TDP-43 prevents retrotransposon activation in the Drosophila motor system through regulation of Dicer-2 activity

  2020cites this paper
• Modulating microRNA Processing: Enoxacin, the Progenitor of a New Class of Drugs

  2020cites this paper
• RNAi-mediated control of CRISPR functions

  2020cites this paper
• Efficacy of Ciprofloxacin/Celecoxib combination in zebrafish models of amyotrophic lateral sclerosis

  2020cites this paper
• Selective toxicity of antibacterial agents—still a valid concept or do we miss chances and ignore risks?

  2020cites this paper
• The critical impacts of small RNA biogenesis proteins on aging, longevity and age-related diseases.

  2020cites this paper
• Zika virus infection induces RNAi-mediated antiviral immunity in human neural progenitors and brain organoids

  2019cites this paper
• Significant Role of Dicer and miR-223 in Adipose Tissue of Polycystic Ovary Syndrome Patients

  2019cites this paper
• A review of currently identified small molecule modulators of microRNA function.

  2019cites this paper
• Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness

  2019cites this paper
• The Capsid Protein of Semliki Forest Virus Antagonizes RNA Interference in Mammalian Cells

  2019cites this paper
• Repositioning of fluoroquinolones from antibiotic to anti-cancer agents: An underestimated truth.

  2019cites this paper
• Roles of microRNAs in Parkinson’s and other neurodegenerative diseases

  2019cites this paper
• MicroRNA‑192 acts as a tumor suppressor in colon cancer and simvastatin activates miR‑192 to inhibit cancer cell growth.

  2019cites this paper
• Endogenous TDP-43 prevents retrotransposons activation through Dicer-2 activity and the RNA silencing machinery in Drosophila neurons

  2019cites this paper
• Prediction of Small Molecule-MicroRNA Associations by Sparse Learning and Heterogeneous Graph Inference.

  2019cites this paper
• Pharmacological boost of DNA damage response and repair by enhanced biogenesis of DNA damage response RNAs

  2019cites this paper
• The dual luciferase reporter system and RT‐qPCR strategies for screening of MicroRNA‐21 small‐molecule inhibitors

  2019cites this paper
• Cerebral Amyloid Angiopathy, Alzheimer’s Disease and MicroRNA: miRNA as Diagnostic Biomarkers and Potential Therapeutic Targets

  2019cites this paper
• Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics

  2019cites this paper
• Impaired miRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness

  2018cites this paper
• MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors

  2018cites this paper
• Cell-Based Reporter System for High-Throughput Screening of MicroRNA Pathway Inhibitors and Its Limitations

  2018cites this paper
• Investigating microRNA-7 as a potential therapeutic in cancer

  2018cites this paper
• Enoxacin extends lifespan of C. elegans by inhibiting miR-34-5p and promoting mitohormesis

  2018influential citation
• Piperine ameliorates SCA17 neuropathology by reducing ER stress

  2018cites this paper